Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantat... von van de Donk, Niels W.C.J., Kröger, Nicolaus, Hegenbart, Ute, Corradini, Paolo, Miguel, Jesus F. San, Goldschmidt, Hartmut, Perez-Simon, Jose A., Zijlmans, Mark, Raymakers, Reinier A., Montefusco, Vittorio, Ayuk, Francis A., van Oers, Marinus H.J., Nagler, Arnon, Verdonck, Leo F., Lokhorst, Henk M.

Volltext

Lenalidomide for the treatment of relapsed and refractory multiple myeloma von van de Donk, Niels Wcj, Görgün, Güllü, Groen, Richard Wj, Jakubikova, Jana, Mitsiades, Constantine S, Hideshima, Teru, Laubach, Jacob, Nijhof, Inger S, Raymakers, Reinier A, Lokhorst, Henk M, Richardson, Paul G, Anderson, Kenneth C

Volltext

Induction of LFA-1 on Pluripotent CD34+ Bone Marrow Cells Does Not Affect Lineage Commitment von Torensma, Ruurd, Raymakers, Reinier A.P., van Kooyk, Yvette, Figdor, Carl G.

Volltext

Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity von van der Kolk, Dorina M., Vellenga, Edo, van der Veen, Anneke Y., Noordhoek, Leonore, Timmer-Bosscha, Hetty, Ossenkoppele, Gert J., Raymakers, Reinier A., Müller, Michael, van den Berg, Eva, de Vries, Elisabeth G. E.

Volltext

A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients von Kneppers, E, Lokhorst, H, Eeltink, C, Huls, G, Wittebol, S, Kersten, MJ, Raymakers, RA, Schaafsma, M, Sonneveld, P, Vellenga, E, Wijermans, P, Zweegman, S

Volltext